Fair Play for Children

Skip to main content eAlerts Register Login medwireNews Medicine Matters SEARCH Medicine Matters Diabetes Neurology Oncology Ophthalmology Respiratory Rheumatology More therapy areas subNavigationMarker main-content 10-12-2019 | Haematology | Video Ching-Hon Pui discusses phase 3 findings showing improved survival with dasatinib versus imatinib given alongside intensive chemotherapy for the treatment of children with Philadelphia chromosome-positive acute lymphoblastic leukaemia (3:47). Funding for independent interviews at ASH 2019 was provided by F. Hoffmann-La Roche Ltd, Basel, Switzerland. Putting research into context. Saving you time. Keeping you informed. Follow us About us Our mission and values Range of services FAQs: Users FAQs: Commercial partners Testimonials Contact us Information for partners For healthcare professionals For societies For funders Licensing medwireNews Scope of expertise Legal information Terms of use Privacy statement Cookies AddThis Sharing Buttons Share to Email App Share to Print Share to LinkedIn Share to Twitter Share to Facebook Share to Pinterest Share to More © 2020 Springer Healthcare is part of the Springer Nature Group Version: 20191227084901_0.502.0_e834ec2 We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners. Privacy-Statement Accept Cookies Cookie Settings



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More